Pharmaceuticals Financial News

batteries have taken centre stage. As major automotive markets rapidly embrace EVs, there's a robust demand for batteries, opening vast opportunities for EV battery manufacturers. Companies, big and small, are now diversifying with an eye on the EV battery value chain.

Federal officials have cleared the way for Florida to begin importing cheaper prescription drugs from Canada

J B Chemicals & Pharmaceuticals with a target price of Rs 1800. The current market price of the stock is Rs 1593.15. J B Chemicals & Pharmaceuticals Ltd, incorporated in the year 1976, is a mid-cap company (having a market cap of Rs 24672.02 crore) operating in pharmaceuticals sector.

Explore Wall Street's expert insights with this ProResearch article, which will exclusively be available to InvestingPro subscribers soon. Enhance your investment strategy with ProPicks, our newest product featuring strategies that have outperformed the S&P 500 by up to 700%. This New Year, enjoy up to 50% off, plus an extra 10% off a 2-year subscription with the code research23 , reserved for the first 500 quick subscribers. To ensure ongoing access to valuable content like this, step up your investment game with InvestingPro.

Explore Wall Street's expert insights with this ProResearch article, which will exclusively be available to InvestingPro subscribers soon. Enhance your investment strategy with ProPicks, our newest product featuring strategies that have outperformed the S&P 500 by up to 700%. This Cyber Monday, enjoy up to 60% off, plus an extra 10% off a 2-year subscription with the code research23 , reserved for the first 500 quick subscribers. To ensure ongoing access to valuable content like this, step up your investment game with InvestingPro.

Check out the companies making headlines in midday trading.

Glenmark Pharmaceuticals Ltd's Long-Term Issuer Default Rating (IDR) at 'BB' following the disclosure of its intention to sell a 75% ownership in its active pharmaceutical ingredient (API) business, held under subsidiary Glenmark Life Sciences Ltd. The outlook is 'Stable', according to the international credit rating agency release today.

Chandraprakash Padiyar, Senior Fund Manager, Tata MF, says “all parts of home improvement look quite attractive to us. Whereas it is more about company specific within the sector that you choose from for your portfolio. But if you look at the general growth trends for the overall sector, I would say that the next three-five years look quite interesting for the overall home improvement sector. Within our portfolio, we are more towards the plywood space and sanitaryware ceramics.”What are your thoughts on this valuation argument for the broader market versus the larger cap universe? The argument now coming out is that the larger cap universe is much more fairly valued and mid and smallcaps have run way ahead of fundamentals and hence the tilt should be towards the largecaps. Do you subscribe to this argument?On largecap versus mid and smallcaps, I also at this point in time, maybe for the next 12 months or so, belong to the same camp which says that there is reasonable valuation on the largecap side and a part of midcaps and small caps may have run beyond fundamentals for a short period of time.

Stocks that traded heavily or had substantial price changes on Wednesday: Rocket Pharmaceuticals, Moderna rise; American Airlines, Spirit Airlines fall

Suven Pharmaceuticals jumped 6.6% to Rs 551 in Thursday's trade on BSE after the Union Cabinet on Wednesday approved a Rs 9,589 crore foreign direct investment (FDI) proposal by a Cyprus-based firm in the company. As per the proposed deal, Cyprus-based Berhyanda will acquire 76.1% equity shares of Hyderabad-headquartered Suven Pharmaceuticals. With the new deal, the aggregate foreign investment in Suven Pharmaceuticals will increase to 90.1%. An official statement released after the Cabinet Committee on Economic Affairs (CCEA) meeting also mentioned that this approval was granted following a thorough evaluation of the proposal by relevant departments, the Reserve Bank of India (RBI), and the Securities and Exchange Board of India (SEBI). At 10.55 am, the stock was trading 1.4% higher on BSE.

(Reuters) — Teva Pharmaceuticals will pay a fine of $225 million over five years to settle the criminal price-fixing charges brought against Teva in 2020 by the U.S. Department of Justice, the company said on Monday.

Teva Pharmaceuticals, a leading generic pharmaceutical company, is taking proactive measures to reduce its environmental impact by partnering with Honeywell, a technology company, to optimize energy consumption and carbon emissions at its manufacturing facility in Debrecen, Hungary.

Relative Strength Index (RSI) can help investors understand the movement of stocks to make informed decisions. On July 4, Tuesday, StockEdge reported 10 stocks with RSI trending up. Among this group, ETMarkets has identified 10 stocks that are currently trading in an overbought zone.

In this article

In this article

Take a look at some of the biggest movers in the premarket:

In this article